| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.25 | 0.002 |